A detailed history of Camden Capital, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Camden Capital, LLC holds 12,661 shares of JNJ stock, worth $2.03 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
12,661
Previous 15,997 20.85%
Holding current value
$2.03 Million
Previous $2.53 Million 26.88%
% of portfolio
0.15%
Previous 0.22%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$144.38 - $157.78 $481,651 - $526,354
-3,336 Reduced 20.85%
12,661 $1.85 Million
Q1 2024

May 15, 2024

BUY
$155.22 - $162.74 $412,729 - $432,725
2,659 Added 19.94%
15,997 $2.53 Million
Q4 2023

Feb 05, 2024

BUY
$145.6 - $158.88 $756,828 - $825,858
5,198 Added 63.86%
13,338 $2.09 Million
Q3 2023

Nov 03, 2023

BUY
$155.75 - $174.48 $204,188 - $228,743
1,311 Added 19.2%
8,140 $1.27 Million
Q2 2023

Aug 09, 2023

BUY
$154.35 - $166.11 $404,860 - $435,706
2,623 Added 62.36%
6,829 $1.13 Million
Q1 2023

May 11, 2023

SELL
$151.05 - $180.26 $27,189 - $32,446
-180 Reduced 4.1%
4,206 $651,000
Q4 2022

Feb 13, 2023

SELL
$160.2 - $179.79 $134,568 - $151,023
-840 Reduced 16.07%
4,386 $774,000
Q3 2022

Nov 08, 2022

BUY
$161.33 - $179.52 $260,386 - $289,745
1,614 Added 44.68%
5,226 $854,000
Q2 2022

Aug 03, 2022

SELL
$168.19 - $186.01 $37,338 - $41,294
-222 Reduced 5.79%
3,612 $641,000
Q1 2022

May 06, 2022

BUY
$158.14 - $179.59 $45,860 - $52,081
290 Added 8.18%
3,834 $680,000
Q4 2021

Feb 28, 2022

SELL
$155.93 - $173.01 $832,666 - $923,873
-5,340 Reduced 60.11%
3,544 $606,000
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $404,482 - $448,787
-2,594 Reduced 22.6%
8,884 $1.52 Million
Q3 2021

Nov 03, 2021

BUY
$161.5 - $179.47 $292,315 - $324,840
1,810 Added 18.72%
11,478 $1.85 Million
Q2 2021

Aug 16, 2021

BUY
$159.48 - $171.07 $88,989 - $95,457
558 Added 6.13%
9,668 $1.59 Million
Q1 2021

May 10, 2021

BUY
$153.07 - $170.48 $500,232 - $557,128
3,268 Added 55.94%
9,110 $1.5 Million
Q4 2020

Feb 04, 2021

BUY
$137.11 - $157.38 $10,831 - $12,433
79 Added 1.37%
5,842 $919,000
Q3 2020

Oct 30, 2020

BUY
$140.38 - $153.83 $84,929 - $93,067
605 Added 11.73%
5,763 $858,000
Q2 2020

Aug 11, 2020

SELL
$128.81 - $155.51 $246,413 - $297,490
-1,913 Reduced 27.05%
5,158 $725,000
Q1 2020

Apr 13, 2020

BUY
$111.14 - $153.99 $35,342 - $48,968
318 Added 4.71%
7,071 $930,000
Q4 2019

Feb 10, 2020

BUY
$127.5 - $146.44 $861,007 - $988,909
6,753 New
6,753 $985,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $419B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Camden Capital, LLC Portfolio

Follow Camden Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camden Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camden Capital, LLC with notifications on news.